Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study



Status:Archived
Conditions:Depression
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:June 2010
End Date:June 2012

Use our guide to learn which trials are right for you!

Targeted and Tailored Messages to Enhance Depression Care


This trial consists of two linked substudies.

Substudy 1: Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness
Study

Substudy 2: Activating Messages for Enhancing Primary Care Practice (AMEP2): Toxicity
Study

The purpose of the Effectiveness Study is to assess the comparative effectiveness of three
multimedia educational interventions (a targeted educational video, a tailored interactive
multimedia computer program, and an "attention control") for increasing the likelihood that
primary care patients with significant depressive symptoms will seek appropriate care (n =
510). The primary study outcomes are provision of minimally acceptable initial care,
reductions in depression-related stigma, and improvement in depression symptoms. (See
Process of Care and Patient Outcomes in Primary Outcome Measure section.)

The purpose of the Toxicity Study is to assess the potential benefits (reduced stigma) and
harms (inappropriate prescribing) associated with three multimedia depression educational
interventions when administered to patients with few or no depressive symptoms (n = 308).
The primary outcomes relating to this outcome are reducing depression-related stigma and
reducing unnecessary prescribing. (See Toxicity in Primary Outcome Measure section.)

Both studies will look at the secondary outcome measure of patient requests for depression
treatment.


This project is an investigator-initiated study involving two sequential phases and is
funded by the National Institute of Mental Health. Phase I included the use of marketing
research (i.e. focus groups, adaptive conjoint analysis, and other survey methods) to
produce two clinic-based interventions: a public service announcement (PSA) and interactive
multimedia computer program (IMCP). The two clinic-based interventions are intended to
include messages that will activate patients to talk with their physicians about specific
health concerns (depression) and/or any depressive symptoms they've been experiencing. In
Phase II (as described in this registration protocol), those interventions will undergo
assessment in a randomized controlled effectiveness trial (RCT) in primary care settings in
Sacramento and San Francisco.


We found this trial at
2
sites
San Francisco, California 94115
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Orange, California 92868
?
mi
from
Orange, CA
Click here to add this to my saved trials